Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19 : a randomized clinical trial
| Cyhoeddwyd yn: | Nature Cancer 4(2023)1, S. 96-107 |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Erthygl |
| Iaith: | English |
| Cyhoeddwyd: |
2023
|
| Pynciau: | |
| Mynediad Ar-lein: | https://doi.org/10.1038/s43018-022-00503-w |
| Eitemau Perthynol: | In:
Nature Cancer |
| Disgrifiad o'r Eitem: | Exemplar/Standort: Open Access |
|---|---|
| DOI: | 10.1038/s43018-022-00503-w |
| Rhif Galw: | Open Access |